These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2789052)

  • 21. Strain differences in the antitumor activity of an immunopotentiator, Nocardia rubra cell-wall skeleton, in B10 congenic and recombinant mice.
    Haraguchi S; Kurakata S; Matsuo T; Yoshida TO
    Jpn J Cancer Res; 1985 May; 76(5):400-13. PubMed ID: 2989065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local conditions in the host influence immunotherapy with interleukin-2 and LAK cells.
    Steller EP; Ottow RT; Eggermont AM; Marquet RL; Sugarbaker PH
    Cancer Detect Prev; 1988; 12(1-6):81-90. PubMed ID: 3263202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
    Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-2 does not overcome suppression of graft rejection by cyclosporin A: effect of cyclosporin A on T cell properties in vivo.
    Magae J; Matsubara H; Aotsuka N; Kurasawa K; Shearer GM
    Cell Immunol; 1996 Nov; 173(2):276-81. PubMed ID: 8912887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysaccharide fraction of Agaricus brasiliensis avoids tumor-induced IL-10 production and changes the microenvironment of subcutaneous Ehrlich adenocarcinoma.
    Pinto AV; Martins PR; Romagnoli GG; Campanelli AP; Terezan AP; Filho ER; Ferreira da Eira A; Kaneno R
    Cell Immunol; 2009; 256(1-2):27-38. PubMed ID: 19243740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cimetidine inhibits angiogenesis and suppresses tumor growth.
    Natori T; Sata M; Nagai R; Makuuchi M
    Biomed Pharmacother; 2005; 59(1-2):56-60. PubMed ID: 15740937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effect of avermectins.
    Drinyaev VA; Mosin VA; Kruglyak EB; Novik TS; Sterlina TS; Ermakova NV; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
    Eur J Pharmacol; 2004 Oct; 501(1-3):19-23. PubMed ID: 15464058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antitumor effect of a water-in-oil-in-water type adriamycin emulsion on Ehrlich solid tumor-bearing mice].
    Mimaki Y; Shinozawa S; Yasuda K; Yao K; Etwo K; Fukuda T; Araki Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):467-72. PubMed ID: 7184409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine.
    Sunila ES; Kuttan G
    J Ethnopharmacol; 2004 Feb; 90(2-3):339-46. PubMed ID: 15013199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-gamma and restrains serum sialic acid and gamma glutamyl transpeptidase production in tumor - bearing animals.
    Guruvayoorappan C; Kuttan G
    J Exp Ther Oncol; 2007; 6(4):285-95. PubMed ID: 18038762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
    Abbud-Filho M; Kupiec-Weglinski JW; Araujo JL; Heidecke CD; Tilney NL; Strom TB
    J Immunol; 1984 Nov; 133(5):2582-6. PubMed ID: 6237152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cell-mediated immune function in NPC patients treated with cimetidine].
    Zeng P; Xiao J; Lei Y
    Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):223-5. PubMed ID: 7656832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interference of various hormonal therapy on the growth of Ehrlich's ascites tumor cells and the antitumoral activity of 5-fluorouracil].
    Melan F; Napoli PA; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(3):271-83. PubMed ID: 5737808
    [No Abstract]   [Full Text] [Related]  

  • 37. Interleukin-4 treatment restores cellular immunity after ethanol exposure and burn injury.
    Messingham KA; Heinrich SA; Schilling EM; Kovacs EJ
    Alcohol Clin Exp Res; 2002 Apr; 26(4):519-26. PubMed ID: 11981129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation of interleukin-2 immunotherapeutic effects by lymphokine-activated killer cells and allogeneic stimulation in murine tumor cells.
    Eggermont AM; Steller EP; Ottow RT; Matthews W; Sugarbaker PH
    J Natl Cancer Inst; 1987 Nov; 79(5):983-90. PubMed ID: 3500357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunomodulating properties of bidistilled modified water].
    Fesenko EE; Novoselova EG; Ogaĭ VB; Agafonova TA; Glushkova OV; Sinotova OA; Aliushev FK; Eremin SM; Markov IA; Ten IuA
    Biofizika; 2001; 46(2):353-8. PubMed ID: 11357353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.